14.41
price down icon0.96%   -0.14
after-market Handel nachbörslich: 14.42 0.010 +0.07%
loading
Schlusskurs vom Vortag:
$14.55
Offen:
$14.4
24-Stunden-Volumen:
1.58M
Relative Volume:
0.96
Marktkapitalisierung:
$12.03B
Einnahmen:
$3.85B
Nettoeinkommen (Verlust:
$667.93M
KGV:
21.93
EPS:
0.657
Netto-Cashflow:
$142.30M
1W Leistung:
-0.83%
1M Leistung:
-5.38%
6M Leistung:
-4.51%
1J Leistung:
-10.02%
1-Tages-Spanne:
Value
$14.33
$14.46
1-Wochen-Bereich:
Value
$14.33
$14.77
52-Wochen-Spanne:
Value
$12.26
$16.89

Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile

Name
Firmenname
Dr Reddys Laboratories Ltd Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
27,811
Name
Twitter
@drreddys
Name
Nächster Verdiensttermin
2025-07-23
Name
Neueste SEC-Einreichungen
Name
RDY's Discussions on Twitter

Vergleichen Sie RDY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
RDY
Dr Reddys Laboratories Ltd Adr
14.41 12.09B 3.85B 667.93M 142.30M 0.657
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
151.19 68.05B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.55 46.58B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.65 43.71B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.29 18.40B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.89 13.23B 2.99B 1.21B 1.13B 25.06

Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-05 Hochstufung HSBC Securities Hold → Buy
2024-12-19 Herabstufung Nomura Buy → Neutral
2024-01-11 Herabstufung Jefferies Buy → Underperform
2023-08-29 Herabstufung HSBC Securities Buy → Hold
2023-05-18 Herabstufung Bernstein Outperform → Mkt Perform
2023-03-17 Hochstufung BofA Securities Neutral → Buy
2023-01-30 Eingeleitet JP Morgan Underweight
2022-11-14 Herabstufung Credit Suisse Neutral → Underperform
2022-01-03 Fortgesetzt BofA Securities Neutral
2021-07-27 Herabstufung Credit Suisse Outperform → Neutral
2021-02-02 Hochstufung Barclays Equal Weight → Overweight
2020-09-18 Hochstufung BofA Securities Neutral → Buy
2020-09-18 Hochstufung Investec Sell → Hold
2020-01-28 Herabstufung CLSA Buy → Outperform
2020-01-27 Herabstufung CLSA Buy → Outperform
2020-01-09 Hochstufung Citigroup Sell → Buy
2019-11-04 Herabstufung BofA/Merrill Buy → Neutral
2019-09-04 Hochstufung Credit Suisse Underperform → Outperform
2019-07-01 Hochstufung Macquarie Neutral → Outperform
2019-06-20 Eingeleitet Deutsche Bank Hold
2019-06-11 Eingeleitet Barclays Equal Weight
2019-05-20 Herabstufung Morgan Stanley Overweight → Equal-Weight
2019-02-19 Hochstufung CLSA Outperform → Buy
2019-01-17 Herabstufung Citigroup Neutral → Sell
2017-09-21 Hochstufung Morgan Stanley Equal-Weight → Overweight
2017-08-31 Hochstufung CLSA Underperform → Outperform
2017-07-28 Herabstufung CLSA Underperform → Sell
2016-07-27 Herabstufung HSBC Securities Hold → Reduce
2016-07-27 Herabstufung Jefferies Hold → Underperform
2016-02-10 Hochstufung Credit Agricole Underperform → Buy
2015-11-10 Herabstufung Citigroup Buy → Neutral
Alle ansehen

Dr Reddys Laboratories Ltd Adr Aktie (RDY) Neueste Nachrichten

pulisher
Jul 22, 2025

Dr Reddys Q1 Results Preview: Analysts Outlook Mixed, See Double-Digit Growth - NDTV Profit

Jul 22, 2025
pulisher
Jul 22, 2025

Asian Stocks Mixed As S&P Asia 50 ADR Index Falls - Finimize

Jul 22, 2025
pulisher
Jul 18, 2025

HSBC Upgrades Dr. Reddy’s Laboratories Limited (RDY) to Buy from Hold - MSN

Jul 18, 2025
pulisher
Jul 17, 2025

LLY Stock Quote Price and Forecast - CNN

Jul 17, 2025
pulisher
Jul 16, 2025

Asian ADRs Retreat As Mixed Results Hit The Market - Finimize

Jul 16, 2025
pulisher
Jul 14, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Jul 14, 2025
pulisher
Jul 14, 2025

Morgan Stanley initiates coverage on Dr. Reddy’s stock with Equalweight rating - Investing.com India

Jul 14, 2025
pulisher
Jul 11, 2025

Functional Dyspepsia Market Analysis and Forecast, 2025-2035, Competitive Analysis of AstraZeneca, P&G, Takeda, Prestige Consumer Healthcare, Kenvue Brands, Dr. Reddy's, Pfizer, ZERIA, Daewoong - GlobeNewswire Inc.

Jul 11, 2025
pulisher
Jul 09, 2025

Allspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy’s Laboratories Ltd (NYSE:RDY) - Defense World

Jul 09, 2025
pulisher
Jul 08, 2025

BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jul 08, 2025
pulisher
Jul 07, 2025

Mixed Movements In Asian Equities As Some Sectors Shine - Finimize

Jul 07, 2025
pulisher
Jul 07, 2025

Full Truck Alliance Co. Ltd. Sponsored ADR (NYSE:YMM) Shares Acquired by Mirae Asset Global Investments Co. Ltd. - Defense World

Jul 07, 2025
pulisher
Jul 06, 2025

Mather Group LLC. Buys 3,413 Shares of Haleon PLC Sponsored ADR (NYSE:HLN) - Defense World

Jul 06, 2025
pulisher
Jun 29, 2025

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Holdings Cut by Robeco Institutional Asset Management B.V. - MarketBeat

Jun 29, 2025
pulisher
Jun 17, 2025

Asian ADRs Climb With North And South Leaders - Finimize

Jun 17, 2025
pulisher
Jun 16, 2025

Dr Reddy’s Breaks Past ₹1,330 Apex: SEBI RA Rajneesh Sharma Sees Trend Shift, Cautions Overbought Zone - Investing.com India

Jun 16, 2025
pulisher
Jun 16, 2025

Dr Reddys Laboratories allots Equity shares - Business Standard

Jun 16, 2025
pulisher
Jun 13, 2025

RDY’s Market Whiplash: 2.41% YTD Rise, 14.68% Rise in 30 Days - investchronicle.com

Jun 13, 2025
pulisher
Jun 13, 2025

SBI Cards to WiproPrashanth Tapse suggests stocks to buy in the short term - Mint

Jun 13, 2025
pulisher
Jun 11, 2025

Stocks Showing Rising Market Leadership: Dr. Reddy's Labs ADR Earns 81 RS Rating - Investor's Business Daily

Jun 11, 2025
pulisher
Jun 11, 2025

Yatsen And Zai Lab Shine As Asian ADRs Climb In The US - Finimize

Jun 11, 2025
pulisher
Jun 05, 2025

Dr. Reddy’s stock rises on biosimilar collaboration with Alvotech By Investing.com - Investing.com Nigeria

Jun 05, 2025
pulisher
Jun 05, 2025

Dr. Reddy’s stock rises on biosimilar collaboration with Alvotech - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

HSBC upgrades Dr. Reddy’s stock rating citing semaglutide prospects - Investing.com Australia

Jun 05, 2025
pulisher
May 27, 2025

Asian Equities Gain In US Markets' Positive Start - Finimize

May 27, 2025
pulisher
May 27, 2025

Dr. Reddy’s Laboratories Receives USFDA Observations After Recent Inspection - TipRanks

May 27, 2025
pulisher
May 22, 2025

Bank of America Corp DE Buys 1,057,584 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat

May 22, 2025
pulisher
May 20, 2025

Dr Reddys Laboratories shares climb over 1.1% amid increased trading volume in today's session - Moneycontrol

May 20, 2025
pulisher
May 14, 2025

Axa S.A. Has $1.23 Million Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat

May 14, 2025
pulisher
May 13, 2025

Indian ADRs Surge in US Markets as Wall Street soars after US-China trade talks - Moneycontrol

May 13, 2025
pulisher
May 12, 2025

Shares To Buy For Short-term: Analysts recommend 5 largecap, 2 midcap stocks; Britannia, Dr Reddy's, TCS on the list - Zee Business

May 12, 2025
pulisher
May 11, 2025

Wells Fargo & Company MN Has $124,000 Holdings in Dr. Reddy’s Laboratories Limited (NYSE:RDY) - Defense World

May 11, 2025
pulisher
May 10, 2025

Asian Equities Climb Despite Weekly Losses - Finimize

May 10, 2025
pulisher
May 09, 2025

Dr. Reddy’s Earnings: Year-End Numbers Look Solid as Demand and Prescription Trends Remain Resilient - Morningstar

May 09, 2025
pulisher
May 09, 2025

Dr. Reddy’s Laboratories Grants Stock Options to Employees in May 2025 - TipRanks

May 09, 2025
pulisher
May 09, 2025

Insider’s View: Deciphering Six Flags Entertainment Corp (FUN)’s Financial Health Through Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Balance Sheet Breakdown: Astrazeneca plc ADR (AZN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Ratio Examination: Dr. Reddy’s Laboratories Ltd. ADR (RDY)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 09, 2025
pulisher
May 09, 2025

Metric Deep Dive: Understanding Phio Pharmaceuticals Corp (PHIO) Through its Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Financial Analysis: Spotify Technology S.A (SPOT)’s Ratios Unveil Key Insights - DWinneX

May 09, 2025
pulisher
May 09, 2025

5 Indian ADRs crash up to 14% amid rising India-Pakistan military conflict - Trade Brains

May 09, 2025
pulisher
May 09, 2025

Q4 Results Highlights: Dr. Reddy's Laboratories profit rises 22% YoY to ₹1,594 crore, dividend recommended - Upstox

May 09, 2025
pulisher
May 08, 2025

Indian Markets Set for Bloody Friday as Gift Nifty Signals Sharp Gap-Down Open Amid Escalating India-Pak Tensions - outlookbusiness.com

May 08, 2025
pulisher
May 08, 2025

Indian ADRs slump as India-Pakistan conflict sees escalation - Moneycontrol

May 08, 2025
pulisher
May 08, 2025

Gift Nifty, India ADRs see sharp sell-off following escalation in India-Pakistan conflict - Moneycontrol

May 08, 2025

Finanzdaten der Dr Reddys Laboratories Ltd Adr-Aktie (RDY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$132.75
price up icon 0.70%
$9.24
price up icon 3.82%
$297.89
price up icon 1.63%
$14.93
price up icon 1.70%
$16.29
price down icon 0.12%
Kapitalisierung:     |  Volumen (24h):